MCV-ACYW135 Vaccine Group
2013L01041
Phase 3 mab completed
Quick answer
MCV-ACYW135 Vaccine Group for Meningitis is a Phase 3 program (mab) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Indication
- Meningitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed